PFBT
AUPH icon

Parkside Financial Bank & Trust’s Aurinia Pharmaceuticals AUPH Stock Holding History

Parkside Financial Bank & Trust’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.04K Hold
120
– – ﹤0.01% 2182
2026
Q1 		$1.78K Hold
120
– – ﹤0.01% 2157
2025
Q4 		$1.91K Hold
120
– – ﹤0.01% 2114
2025
Q3 		$1.33K Hold
120
– – ﹤0.01% 2168
2025
Q2 		$1.02K Buy
+120
New +$962 ﹤0.01% 2265

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parkside Financial Bank & Trust's AUPH Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its Aurinia Pharmaceuticals (AUPH) position steady in Q2 2026 at 120 shares worth $2.04K. The position accounts for ﹤0.01% of the portfolio, ranked #2182.

Parkside Financial Bank & Trust first reported a position in AUPH in Q2 2025 and has held it in 5 quarters since. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Parkside Financial Bank & Trust held 120 shares of Aurinia Pharmaceuticals worth $2.04K as of Q2 2026.
  • Parkside Financial Bank & Trust left its Aurinia Pharmaceuticals share count unchanged in Q2 2026.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2182 holding.
  • Parkside Financial Bank & Trust first reported a position in Aurinia Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.